Aclarion, Inc. (ACON) vs Renalytix plc - Sponsored ADR (RNLXY)
- Aclarion, Inc. ACON 1.66 +6.41%
- Renalytix plc - Sponsored ADR RNLXY 3.70 −2.37%
Aclarion, Inc. and Renalytix plc - Sponsored ADR are both Health Information Services companies. Renalytix plc - Sponsored ADR is the larger, with a market value of $17.2M against $4.5M — 3.8× the size. Aclarion, Inc. grew revenue faster over the last twelve months: 46.2% against −18.3%. Renalytix plc - Sponsored ADR has the higher net margin (−1,186.2% vs −10,262.9%) and the higher return on invested capital (0.00% vs −1,120.9%). Across the 16 metrics below, Renalytix plc - Sponsored ADR leads on 9 and Aclarion, Inc. on 7.
Valuation
Profitability
| Metric | ACON | RNLXY | Health Information Services median |
|---|---|---|---|
| Gross margin | 29.12% | 14.52% | 59.61% |
| Operating margin | (10,792.12%) | (1,087.73%) | (10.54%) |
| Net margin | (10,262.89%) | (1,186.20%) | (16.14%) |
| Free cash flow margin | (9,272.40%) | 0.00% | 0.00% |
| Return on equity | (74.07%) | 0.00% | (3.15%) |
| Return on assets | (69.66%) | 0.00% | (5.62%) |
| Return on invested capital | (1,120.88%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack